Long-term treatment with clarithromycin and carbocisteine improves lung function in chronic cough patients with chronic rhinosinusitis
American Journal of Otolaryngology - Head and Neck Medicine and Surgery Nov 29, 2019
Kariya S, et al. - Among chronic cough patients with chronic rhinosinusitis, researchers determined the influence of clarithromycin and carbocisteine on the changes in lung function. For this study, they recruited 32 chronic cough patients with chronic rhinosinusitis. They excluded cases using inhaled corticosteroids and/or a bronchodilator, asthmatic patients, and cases with abnormal findings on auscultation and/or chest X-ray examination. For 3 months, low-dose clarithromycin treatment was administered to the patients. The long-duration therapy with macrolide antibiotics resulted in improvements in both the lung function and Lund-MacKay computed tomography scores. In non-asthmatic chronic cough patients with normal chest X-ray findings, the beneficial influences of macrolide antibiotics treatment were evident in this study. The improvement of chronic rhinosinusitis was suggested to possibly have some role in the lung condition. The possible usefulness of upper respiratory tract examination and treatment was suggested for the management of chronic cough.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries